New silicone implant aims to treat fecal incontinence
NCT ID NCT05708612
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a silicone implant called SimplyFI to treat chronic fecal incontinence in people who haven't gotten better with standard treatments. The implant is placed during a procedure and aims to improve bowel control. Researchers are checking how safe it is and how well it works over 12 months in 36 adults.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
silicone implant (SimplyFI)
What this could lead to
If successful, this implant could offer a new, less invasive surgical option to help control fecal incontinence and improve quality of life.
What could go wrong
This is a small, early-stage study with only 36 participants. The implant may cause complications or not work for everyone, and long-term results are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FECAL INCONTINENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Göttlicher Heiland Krankenhaus
Vienna, Austria
-
Hospital Ruber Internacional
Madrid, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, Spain
-
Klinikum Bielefeld Rosenhöhe
Bielefeld, Germany
-
Medical University Vienna
Vienna, Austria